This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: EMBARK Study Post-Hoc Analysis By Age - Enzalutamide +/- Leuprolide in Patients With High-Risk Biochemically Recurrent Prostate Cancer

58 views
September 27, 2024
Comments 0
Login to view comments. Click here to Login